High-throughput screening, traditionally the domain of big ... “We're looking at drug-proteome interactions,” says Gitte Neubauer, vice president of research operations at Cellzome, who ...

The global high throughput screening market had an estimated valuation of USD 25.7 billion in 2023 and is expected to reach a size of USD 92.5 billion by 2034, increasing at a CAGR of 10.5% between ...

High-throughput screening still has a long way to go if it is to achieve its often-touted potential. Screening for a drug is often likened to searching for a needle in a haystack. In fact ...

At the forefront of scientific inquiry lies the transformative potential of high-throughput screening in advancing drug discovery. Through the ingenious integration of cutting-edge technologies and ...

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...

Scientists in China say cheap compound might offer relief for craniopharyngioma patients and inform future work on cancer ...

High Content Screening IndustryThe global high content screening (HCS) industry is poised for substantial growth, surpassing USD 1.7 billion in 2023. With a projected compound annual growth rate (CAGR ...

The new system accommodates the latest 96-well μCTS plate, offering an industry standard high-throughput ... rapid screening with reduced cell requirements - benefitting drug developers by ...

Researchers from Chinese Academy of Sciences Institute of Genetics and Developmental Biology discover medication often ...

Axcelead DDP inks drug discovery service agreement with Astellas for targeted protein degraders: Fujisawa, Japan Friday, December 27, 2024, 09:00 Hrs [IST] Axcelead Drug Discovery ...

The Drug Discovery facility provides facilities for organic synthesis, cell culture, analytical chemistry, molecule purification, biochemistry, molecular biology and fluorescent imaging. Core ...